A larger supply increase following those in May and June "would cement the shift in policy from the group--moving from defending prices to defending market share." Traders are also closely monitoring ...

As Bettina Orlopp prepared to address Commerzbank AG ’s annual meeting on Thursday, hundreds of people were holding up protest signs outside the conference hall. Only the employees and shareholders ...

About 200 staff staged the demonstration outside the annual shareholders' meeting of Commerzbank in the German city of Wiesbaden, as the lender fights back against advances from its Italian peer.

Greenwood, SC (29646) Today Sunshine this morning then becoming mostly cloudy this afternoon. High around 85F. Winds WSW at 10 to 15 mph..

Long Term Capital Gains (LTCG) under Section 112A up to Rs 1.25 lakh, provided there is no carry forward of capital loss New addition for FY 2024–25: The ITR-1 form now allows small investors to ...

Commerzbank derived 67% of its Q1 2025 revenue from net interest income—a key concern amid ECB rate cuts. Segment performance was particularly strong at mBank, which saw lower FX mortgage ...

The Commerzbank is currently in a fierce struggle to retain its autonomy as it faces a takeover bid from the Italian bank Unicredit. The German government, which holds a significant stake in ...

Germany backs Commerzbank AG as an independent firm, Finance Minister Lars Klingbeil said Friday, indicating that opposition to the bank’s potential takeover by UniCredit SpA won’t abate under ...

Commerzbank Posts Higher Earnings After Commission ... and their inclusion on this site does not imply any form of partnership, agency, or endorsement. We sell different types of products and ...

The German lender reported its ‘best quarterly result since the first quarter of 2011’ as it attempts to fend off Unicredit’s takeover efforts. Germany’s Commerzbank posted better-than ...

In its 15th year, Verastem Oncology has gained its first FDA approval, winning an accelerated nod for the combination treatment of avutometinib and defactinib for a rare form of ovarian cancer.